Q² Solutions Expands Bioanalytical Capabilities in China
By Default Author
By Default Author
Driving operational improvements and quality of our services
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
DownloadOur commitment to customer success is embedded in every facet of our operations.
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
Driving operational improvements and quality of our services
Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search jobsWe are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
DownloadOur labs bring expertise in protein production, antibody discovery, and immunogenicity to help you select the most promising candidates and reduce risk as you move toward IND-enabling studies.
a CLIA-certified biomarker testing laboratory developing immunoassays used to quantify protein biomarkers in support of drug mechanism of action, pharmacodynamic, prognostic, and predictive clinical studies across all stages of drug discovery and development.
Meeting the demands of today’s drug, device and diagnostics development environment requires a next generation service provider.
One of the world's largest and most respected bioanalytical and ADME laboratory networks. From our global locations, we serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies worldwide.
We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development. Our industry-leading team advances research by delivering scientific insights that help clients maximize the value of their data.
Combining cutting-edge technology platforms and state-of-the-art laboratories with over 35 years of clinical vaccine development.
We have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. We’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency.
By Default Author
Morrisville, N.C. – July 11, 2018 – Q2 Solutions, a global clinical trials laboratory services organization, announced today the expansion of its bioanalytical capabilities in Beijing, China. This expansion includes standardization across our global bioanalytical laboratories in support of regulatory success throughout the drug development continuum.
“Our bioanalytical capabilities expansion in China is an important part of our strategic plan aimed at supporting the needs of the China market and the global drug development needs of our customers around the world,” said Kevin Jones, Q2 Solutions Vice President and General Manager of Bioanalytical and ADME Laboratories.
The bioanalytical operation conducted at the Q2 Solutions Beijing facility is GLP compliant (CFDA and US FDA), delivering reliability and reproducibility to support global clinical pharmacokinetic studies and exploratory biomarker analysis. The facility also includes Q2 Solutions’ Central Laboratory, which is College of American Pathologists (CAP) accredited and was the first lab in China with CAP ISO 15189 certification. This co-located lab helps simplify sample management and reduce transportation costs.
New bioanalytical services include ligand binding based large molecule bioanalysis to supplement existing small molecule liquid chromatography/mass spectrometry (LC/MS) services. Our bilingual team of experts provide dedicated project management, esoteric testing, high-quality data, analytics, sample management, and logistics.
Contact us to learn more about our full set of laboratory services in China, which support a broad spectrum of development needs, with delivery excellence to help ensure high-quality data is generated for regulatory approval in China and throughout the world.
About Q2 Solutions
Launched in 2015, Q2 Solutions is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q2 Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q2 Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities. To learn more, visit www.q2labsolutions.com.
By Default Author